Prediction of response and survival after standardized treatment with 7400 MBq <sup>177</sup>Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer
- Author(s)
- Sazan Rasul, Markus Hartenbach, Tim Wollenweber, Elisabeth Kretschmer-Chott, Bernhard Grubmüller, Gero Kramer, Shahrokh Shariat, Wolfgang Wadsak, Markus Mitterhauser, Verena Pichler, Chrysoula Vraka, Marcus Hacker, Alexander R Haug
- Organisation(s)
- External organisation(s)
- Medizinische Universität Wien, Cornell University, I.M. Sechenov First Moscow State Medical University, Centre for Biomarker Research in Medicine – CBmed GmbH, Charles University Prague, University of Texas, Dallas, Ludwig Boltzmann Intitute Applied Diagnostics
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Volume
- 48
- Pages
- 1650–1657
- No. of pages
- 8
- ISSN
- 1619-7070
- DOI
- https://doi.org/10.1007/s00259-020-05082-5
- Publication date
- 2020
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 302054 Nuclear medicine
- Keywords
- ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/9394e888-10f4-4d59-84f4-3dd8965efc96